510(k) device
AtriClip LAA Exclusion System with Preloaded PRO·V Clip
AtriCure, Inc. · Clip, Implantable (FZP, Class II) · First FDA decision Jun 10, 2010, newest Oct 25, 2017Surgical bleeding and hemostasis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
510(k) pathway
Device trials
11
Naming "AtriClip LAA Exclusion"
MAUDE reports
209
Brand "AtriClip LAA Exclusion", since 2015
PubMed studies
3
Mentioning "AtriClip LAA Exclusion"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AtriClip LAA Exclusion System with Preloaded PRO·V Clip
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
K173031 · Decided Oct 25, 2017 · 27 days after receipt
Device type: Clip, Implantable (FZP) · General & Plastic Surgery
5 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Pulmonary Artery Pressure Sensors for Heart Failure ManagementNational analysisReview closedCAG-00466NUpdated Nov 20, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R3Updated Nov 20, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R2Updated Nov 19, 2026
- Implantable Cardioverter DefibrillatorsNational analysisReview closedCAG-00157R4Updated Nov 19, 2026
- Implantable Pulmonary Artery Pressure Sensors for Heart Failure ManagementNational determinationOn the books20.36Updated Oct 6, 2026
- Implantable Cardioverter Defibrillators (ICDs)National determinationOn the books20.4Updated Sep 28, 2026
- Implantable Defibrillators - Clinical TrialsNational analysisReview closedCAG-00157RUpdated Sep 15, 2026
- Implantable Cardioverter Defibrillators (ICDs)National analysisReview closedCAG-00157NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "AtriClip LAA Exclusion", any status and sponsor, newest update first.
- Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction TrialPivotal-lookingActive, not recruiting
AtriCure, Inc.Public (ATRC)
NCT05478304 · 6,573 participants · Start Jan 25, 2023 · Primary completion Dec 2031
Device: AtriClip LAA Exclusion System · For: Ischemic Stroke; Systemic Embolism
Sites: Huntsville, Alabama; Scottsdale, Arizona; Jonesboro, Arkansas · 138 sites in all
10 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AtriClip LAA Exclusion", and for the whole product code for context.
This brand
209 reports: 128 malfunction, 72 injury, 9 death
Whole product code FZP
25,649 reports: 24,117 malfunction, 1,451 injury, 38 death
Newest reports for this brand
3011706110-2025-00038 · Received Nov 19, 2025
Device type: Left Atrial Appendage Clip, Implantable (PZX)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Thrombosis/Thrombus
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1148-2017 · Started Nov 30, 2016
Reason given: A complaint of the PRO2 jaw breaking prior to surgery being performed.
Cause as FDA categorized it: Component design/selection · Device type: Clip, Implantable (FZP)
1 more recall records with a free account
Published research
The most relevant PubMed records for "AtriClip LAA Exclusion"[tiab]. The summary above synthesizes these.
- Incidence and characteristics of left atrial appendage stumps after device-enabled epicardial closure.
Caliskan E, Eberhard M, Falk V, et al. · Interact Cardiovasc Thorac Surg · 2019Multicenter Study
- Concomitant Left Atrial Appendage Clipping During Minimally Invasive Mitral Valve Surgery: Technically Feasible and Safe.
Alqaqa A, Martin S, Hamdan A, et al. · J Atr Fibrillation · 2016
- Beyond the Maze: Hybrid Ablation and Left Atrial Appendage Occlusion in Cardiac Surgery: Evidence Synthesis and the MESAGE Study Protocol.
Kotoulas SC, Kolovos V, Tsiamis N, et al. · Medicina (Kaunas) · 2026Review
Other devices of this type
Also filed under product code FZP.
- Coalescent Surgical U-Clip and AccessoriesCoalescent Surgical · 510(k) 2004
- Laparoscopic Compression Anastomosis Clip (Lapcac)Niti Medical Technologies , Ltd. · 510(k) 2004
- InnoClip Disposable Clip ApplierTaiwan Surgical Corporation · 510(k) 2025
- Amsel Occluder DeviceAmsel Medical · 510(k) 2017
- Cardica Pas-Port Proximal Anastomosis System, Model FG-000001Cardica, Inc. · 510(k) 2009
- Auto Suture Endo Clip III 5 Mm Clip ApplierUnited States Surgical, A Division of Tyco Healthc · 510(k) 2006
- U-Clip Device, Model NC65Medtronic Vascular · 510(k) 2006
- Modification to Suture ClinchApplied Medical Resources Corp. · 510(k) 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.